Abhiram Gokhale

Employment

• Reliance Life Sciences Pvt Ltd Manager
  2021 - Present
• Indian Institute of Technology Bombay Research Assistant
  2020 - 2020
• Roswell Park Comprehensive Cancer Center Department of Pharmacology and Therapeutics Research Technologist
  2018 - 2020

Education

• University at Buffalo, State University of New York MS Cancer Sciences
  2016 - 2018
• Dr D Y Patil Vidyapeeth University Dr D Y Patil Biotechnology and Bioinformatics Institute M.Tech (integrated) Biotechnology
  2010 - 2015

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• A mitochondrial unfolded protein response inhibitor suppresses prostate cancer growth in mice via HSP60
  Journal of Clinical Investigation 2022 DOI: 10.1172/jci149906
  +Save
• RelCoVax®, a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice
  [] 2022 DOI: 10.1101/2022.01.07.475330
  +Save
• Rapid Classification of COVID-19 Severity by ATR-FTIR Spectroscopy of Plasma Samples
  Analytical Chemistry 2021 DOI: 10.1021/acs.analchem.1c00596
  +Save
• LRIG1, a regulator of stem cell quiescence and a pleiotropic feedback tumor suppressor
  Seminars in Cancer Biology 2021 DOI: 10.1016/j.semcancer.2020.12.016
  +Save
• LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer
  Nature Communications 2019 DOI: 10.1038/s41467-019-13532-4
  +Save
• Radiation Therapy-Induced Metastasis Promotes Secondary Malignancy in Cancer Patients
  2018 DOI: 10.1016/b978-0-12-801238-3.65171-1
  +Save
• Inhibition of Notch signalling has ability to alter the proximal and distal TCR signalling events in human CD3+ αβ T-cells.
  Molecular immunology 2017 DOI: 10.1016/j.molimm.2017.10.013
  +Save